卓昇有限公司–最專業科學研究供應商
50mg (In stock)
C5813-50
CFI-400945
(1S,2R)-2-[3-[(1E)-2-[4-[[(2R,6S)-2,6-dimethyl-4-morpholinyl]methyl]phenyl]ethenyl]-1H-indazol-6-yl]-5'-methoxy-spiro[cyclopropane-1,3'-[3H]indol]-2'(1'H)-one
1338806-73-7
orally available, selective inhibitor of polo-like kinase 4 (PLK4)
98.37%
C33H34N4O3
534.7
insoluble in H2O; ≥109.8 mg/mL in DMSO; ≥93 mg/mL in EtOH
A crystalline solid
C[[C@@H]1O[[C@H](C)CN(CC2=CC=C(/C=C/C3=NNC4=C3C=CC([[C@H]5[[C@H@]6(C(C=C(OC)C=C7)=C7NC6=O)C5)=C4)C=C2)C1
In stock